Company news
Soleno Therapeutics, Inc. news in 2020
Soleno Therapeutics, Inc.'s news releases, calls and decks from 2020, newest first.
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results
November 9, 2020
Soleno Therapeutics Announces Presentation of Body Composition Results from DESTINY PWS, a Phase III Trial of DCCR in Prader-Willi Syndrome
November 2, 2020
Soleno Therapeutics Announces Late-Breaking Oral Presentation with Body Composition Results from Phase III DESTINY PWS Trial of DCCR in Prader-Willi Syndrome at ObesityWeek® 2020 Meeting
October 28, 2020
Soleno Therapeutics Announces Updated Top-line Results from Phase III Trial of DCCR for Treatment of Prader-Willi Syndrome
September 29, 2020
Soleno Therapeutics to Participate in Fireside Chat at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 14, 2020
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results
August 9, 2020
Soleno Therapeutics Added to Russell 3000® Index
June 28, 2020
Soleno Therapeutics Announces Closing of $57.5 Million Public Offering of Common Stock, Including the Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 25, 2020
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
June 23, 2020
Soleno Therapeutics Announces Top-line Results from Phase III Trial of DCCR for Treatment of Prader-Willi Syndrome
June 7, 2020
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
May 11, 2020
Soleno Therapeutics Announces Publication Evaluating Potential Role of Activating ATP-Sensitive Potassium Channel in Treatment of Hyperphagic Obesity
April 22, 2020
Soleno Therapeutics to Present at the 30th Annual Oppenheimer Healthcare Conference
March 10, 2020
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2019 Financial Results
March 3, 2020
Soleno Therapeutics Completes Target Enrollment in Ongoing DESTINY PWS Phase III Trial of DCCR in Prader Willi Syndrome
January 5, 2020
Decks in 2020
- Technical Presentation (June 2020)
Technical · 13 slides · Jun 8, 2020
- Investor Presentation (January 2020)
Investor deck · 26 slides · Jan 10, 2020